Myrexis Inc Cmn Stk
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Market Cap & Net Worth: Myrexis Inc Cmn Stk (MYRX)
Myrexis Inc Cmn Stk (PINK:MYRX) has a market capitalization of $241.35K ($241.35K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50270 globally and #15349 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Myrexis Inc Cmn Stk's stock price $0.01 by its total outstanding shares 34479051 (34.48 Million).
Myrexis Inc Cmn Stk Market Cap History: 2015 to 2025
Myrexis Inc Cmn Stk's market capitalization history from 2015 to 2025. Data shows change from $3.10 Million to $241.35K (-25.98% CAGR).
Myrexis Inc Cmn Stk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Myrexis Inc Cmn Stk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MYRX by Market Capitalization
Companies near Myrexis Inc Cmn Stk in the global market cap rankings as of March 18, 2026.
Key companies related to Myrexis Inc Cmn Stk by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Myrexis Inc Cmn Stk Historical Marketcap From 2015 to 2025
Between 2015 and today, Myrexis Inc Cmn Stk's market cap moved from $3.10 Million to $ 241.35K, with a yearly change of -25.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $241.35K | 0.00% |
| 2024 | $241.35K | +7.69% |
| 2023 | $224.11K | +1200.00% |
| 2022 | $17.24K | -97.50% |
| 2021 | $689.58K | -37.50% |
| 2020 | $1.10 Million | +82.86% |
| 2019 | $603.38K | +59.09% |
| 2018 | $379.27K | -69.01% |
| 2017 | $1.22 Million | -25.73% |
| 2016 | $1.65 Million | -46.89% |
| 2015 | $3.10 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Myrexis Inc Cmn Stk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $241.35K USD |
| MoneyControl | $241.35K USD |
| MarketWatch | $241.35K USD |
| marketcap.company | $241.35K USD |
| Reuters | $241.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.